Cite
HARVARD Citation
Hagiwara, Y. et al. (2018). Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01). European journal of cancer. pp. 79-88. [Online].